The bar chart illustrates the percentage distribution of a drug company’s total sales across three regions—America, Europe, and Asia—over the period from 2002 to 2006.
Overall, the data reveals a notable shift in sales distribution, with Asia experiencing a steady increase, while America and Europe displayed fluctuating trends. Asia’s share of sales grew significantly, from 25% in 2002 to 40% in 2006, making it the region with the largest increase over the period. In contrast, America’s sales proportion declined sharply from 41% in 2002 to 27% in 2004, before recovering slightly to 30% in 2006. Europe’s sales percentage remained relatively stable, fluctuating between 30% and 38%, with its highest share recorded in 2004.
The chart highlights that Asia’s sales growth was consistent, while America experienced a marked decline in its dominance. Europe maintained a middle ground, with minor variations in its share. These trends suggest a shift in market focus towards Asia over the analyzed period.
This response effectively summarizes the main features and trends of the data, with clear comparisons where relevant